We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Clinical Implications of the Evidence from IV Iron Trials in Heart Failure
Stefan D. Anker, MD, PhD
Robert J. Mentz, MD, FHFSA, FACC, FAHA
Piotr Ponikowski, MD, PhD, FESC, FHFA
Incorporating Targeted Therapies in Treatment Planning for AAV
David Jayne, MD
Bernhard Hellmich, MD
What Are the Emerging Therapies for Managing Gout?
Richard Johnson, MD
John K. Botson, MD, RPh
Is Gout Hiding in the Nephrology Clinic?
Abdul Abdellatif, MD, FASN
Can You Manage Patients With Uncontrolled Gout More Effectively?
The Underestimated Consequences of Uncontrolled Gout: Renal and Cardiovascular Implications
Brittany Weber, MD, PhD
What’s New About Gout? Rheumatology Perspective
Center of the Target: Which Patients Are Most Likely to Develop Gout?
What’s New About Gout? Nephrology Perspective
Gout Beyond the Joints: What’s the Hidden Danger?
Treat or Refer: Who Is Responsible for Managing Gout?
Is Managing Gout in the Nephrology Clinic a Challenge?
Should We Look for Gout in the Cardiology Clinic?
2023 ESC Guideline Updates: Where Are We with Iron Deficiency?
Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
Marco Metra, MD
Gianluigi Savarese, MD
A Practical Look at Cardiorenal Protection for CKD in T2D: Applying Recent Data
Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
Maria Luiza Caramori, MD, PhD, MSc
Ana Maria Cebrián-Cuenca, MD, PhD
Pam R. Taub, MD, FACC, FASPC
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education